Laprise C, Laviolette M, Boutet M, Boulet L P
Centre de pneumologie de lHôpital Laval, Université Laval, Sainte-Foy, Québec, Canada.
Eur Respir J. 1999 Jul;14(1):63-73. doi: 10.1034/j.1399-3003.1999.14a12.x.
To study the physiopathology and significance of asymptomatic airway hyperresponsiveness (AHR), the clinical and bronchial immunohistological parameters were evaluated in subjects with asymptomatic and symptomatic AHR. Asymptomatic subjects with AHR (eight females/two males, no respiratory symptoms, provocative concentration of methacholine causing a 20% fall in forced expiratory volume in one second (PC20) <8 mg x mL(-1) and no treatment) were compared with asthmatic subjects paired for age, sex and PC20, and with nonatopic, nonasthmatic controls paired for age and sex. All three groups were evaluated once at baseline, whilst the asymptomatic AHR subjects were re-evaluated after 1 and 2 yrs. Measurements included spirometry, methacholine challenge, serum immunoglobulin (Ig)E, blood eosinophils, and bronchoscopy (at baseline and after 2 yrs only). At first evaluation, the mean blood eosinophil count, total serum IgE level, atopic index, baseline forced expiratory volume in one second (FEV1) and the degree of bronchial epithelial desquamation of the asymptomatic AHR subjects were similar to those of asthmatic subjects. However, they presented focal rather than the continuous bronchial subepithelial fibrosis observed in asthmatics. Their mucosal CD3, CD4, CD25, EG1 and EG2-positive cell counts were intermediate between those of the control subjects and asthmatics. At the end of the 2-yr follow-up, four of them had developed asthma symptoms. At this time, bronchial biopsies revealed an increase in the extent of subepithelial fibrosis and in the number of CD25 and CD4-positive cells, and a decrease in the number of CD8+ cells, particularly in subjects who developed asthma symptoms. These data suggest that asymptomatic airway hyperresponsiveness is associated with airway inflammation and remodelling, and that the appearance of asthma symptoms is associated with an increase in these features, particularly the CD4/CD8 ratio and airway fibrosis. Consequently, this study proposes an association between asymptomatic airway hyperresponsiveness and airway inflammation, structural changes and asthma although these relationships remain to be further evaluated.
为研究无症状气道高反应性(AHR)的病理生理学及意义,我们对无症状和有症状AHR患者的临床及支气管免疫组织学参数进行了评估。将无症状AHR患者(8名女性/2名男性,无呼吸道症状,乙酰甲胆碱激发浓度导致一秒用力呼气量(FEV1)下降20%时的浓度(PC20)<8 mg·mL⁻¹且未接受治疗)与年龄、性别和PC20相匹配的哮喘患者,以及年龄和性别相匹配的非特应性、非哮喘对照者进行比较。所有三组在基线时均进行一次评估,而无症状AHR患者在1年和2年后再次评估。测量指标包括肺功能测定、乙酰甲胆碱激发试验、血清免疫球蛋白(Ig)E、血液嗜酸性粒细胞以及支气管镜检查(仅在基线和2年后进行)。在首次评估时,无症状AHR患者的平均血液嗜酸性粒细胞计数、血清总IgE水平、特应性指数、基线一秒用力呼气量(FEV1)以及支气管上皮剥脱程度与哮喘患者相似。然而,他们表现为局灶性而非哮喘患者中观察到的连续性支气管上皮下纤维化。其黏膜CD3、CD4、CD25、EG1和EG2阳性细胞计数介于对照者和哮喘患者之间。在2年随访结束时,其中4人出现了哮喘症状。此时,支气管活检显示上皮下纤维化范围增加,CD25和CD4阳性细胞数量增加,而CD8⁺细胞数量减少,尤其是在出现哮喘症状的患者中。这些数据表明,无症状气道高反应性与气道炎症和重塑相关,哮喘症状的出现与这些特征的增加相关,特别是CD4/CD8比值和气道纤维化。因此,本研究提出无症状气道高反应性与气道炎症、结构改变和哮喘之间存在关联,尽管这些关系仍有待进一步评估。